Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta

J Immunol. 2005 Dec 1;175(11):7568-74. doi: 10.4049/jimmunol.175.11.7568.

Abstract

NK cells play a key role in host defense against the beta-herpesvirus CMV through perforin-dependent cytolysis. In this study, we show that human NK cells can also control human CMV (HCMV) infection by a noncytolytic mechanism involving induction of IFN-beta in the virus-infected cell. Both IL-2-activated primary NK cells and an IL-2-dependent NK cell line (NK-92) exhibited potent, noncytolytic anti-HCMV activity at very low E:T cell ratios (<0.1:1). Activated NK cells expressed lymphotoxin (LT)alphabeta on their cell surface, and secreted LTalpha and TNF, all of which contributed to the NF-kappaB-dependent release of IFN-beta from infected fibroblasts. IFN-beta produced by fibroblasts and NK cell-produced IFN-gamma combined to inhibit HCMV replication after immediate early gene expression. These results highlight an efficient mechanism used by NK cells to activate IFN-beta expression in the infected target cell that contributes to the arrest of virion production and virus spread without cellular elimination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytomegalovirus / immunology*
  • Fibroblasts / immunology
  • Fibroblasts / metabolism
  • Fibroblasts / virology*
  • Humans
  • Interferon-beta / biosynthesis
  • Interferon-beta / immunology*
  • Interleukin-2 / immunology
  • Killer Cells, Natural / immunology*
  • Lymphotoxin-alpha / biosynthesis
  • Lymphotoxin-alpha / immunology*
  • NF-kappa B / immunology
  • NF-kappa B / metabolism

Substances

  • Interleukin-2
  • Lymphotoxin-alpha
  • NF-kappa B
  • Interferon-beta